This study assessed the buccal administration of a NanoCelle® CBD preparation to healthy volunteers: a safety, tolerability and pharmacokinetic exploratory pilot study.
NanaBidial™ is a non-ARTG product currently in clinical trials and available under SAS. SAS application can be made either manually via the appropriate application forms or on-line via https://sas.tga.gov.au. More info can be found at How to access Medicinal Cannabis
This study was performed on 16 healthy subjects to determine the pharmacokinetics, safety and tolerability characteristics of a novel Cannabidiol formulation in the form or an oro-buccal spray.